Login / Signup

Tyrosine kinase inhibitors (TKIs) used in the management of chronic myeloid leukaemia are associated with haematologic toxicities-Which TKI is the safest?

Ahmet Emre Eskazan
Published in: British journal of clinical pharmacology (2019)
Keyphrases
  • chronic myeloid leukemia
  • tyrosine kinase
  • dendritic cells
  • bone marrow
  • acute myeloid leukemia
  • advanced non small cell lung cancer
  • immune response